Incidence and prognostic value of tumour cells detected by RT–PCR in peripheral blood stem cell collections from patients with Ewing tumour

This publication has 35 references indexed in Scilit:

• Impact of High-Dose Busulfan Plus Melphalan As Consolidation in Metastatic Ewing Tumors: A Study by the Société Française des Cancers de l'Enfant
  Journal of Clinical Oncology, 2006
• Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation
  Zeitschrift für Krebsforschung und Klinische Onkologie, 2004
• Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support
  Transplantation and Cellular Therapy, 2004
• Tumor cells are present in stem cell harvests of Ewings sarcoma patients and their persistence following transplantation is associated with relapse
  Pediatric Blood & Cancer, 2004
• Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)
  Bone Marrow Transplantation, 2003
• Localised Ewing sarcoma/PNET of bone—prognostic factors and international data comparison
  Medical and Pediatric Oncology, 2002
• Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours
  Bone Marrow Transplantation, 1999
• Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcoma
  Bone Marrow Transplantation, 1998
• BRCA1 expression is not directly responsive to estrogen
  Oncogene, 1997
• Detection of (11; 22)(q24;q12) Translocation-Bearing Cells in Peripheral Blood Progenitor Cells of Patients With Ewing's Sarcoma Family of Tumors
  JNCI Journal of the National Cancer Institute, 1995